Suchergebnisse - "Molavipordanjani, Sajjad"

PubPharm (31)

1

99mTc(CO)3-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-HT7 receptors

enthalten in: Annals of nuclear medicine | 2024

von Mardanshahi, A. | Vaseghi, S. | Hosseinimehr, S. | +2

2

99mTc(CO)3-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-$ HT_{7} $ receptors

enthalten in: Annals of nuclear medicine | 2023

von Mardanshahi, A. | Vaseghi, S. | Hosseinimehr, S. | +2

3

Engineering HEK293T cell line by lentivirus to produce miR34a-loaded exosomes

enthalten in: Molecular biology reports | 2023

von Sarkami, S. | Molavipordanjani, S. | Abediankenari, S. | +4

4

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

5

Synthesis and evaluation of 99mTc-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5HT7 receptors

enthalten in: Bioorganic chemistry | 2023

von Karimi, M. | Mardanshahi, A. | Irannejad, H. | +2

6

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

7

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

8

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

9

Initial preclinical evaluation of 68 Ga-DOTA-(Ser) 3 -LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging

enthalten in: Nuclear medicine communications | 2022

von Ranjbar, V. | Molavipordanjani, S. | Biabani Ardakani, J. | +3

10

The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide

enthalten in: Current drug metabolism | 2022

von Gharibkandi, N. | Molavipordanjani, S. | Mardanshahi, A. | +1